Midi Health
Virtual, insurance-covered clinic for perimenopause, menopause, and midlife women's health.
Website: https://www.joinmidi.com
Cover Block
PUBLIC
| Attribute | Details |
|---|---|
| Name | Midi Health |
| Tagline | Virtual, insurance-covered clinic for perimenopause, menopause, and midlife women's health. |
| Headquarters | Palo Alto, California |
| Founded | 2021 |
| Stage | Series D+ |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | $100M+ (total disclosed ~$100,000,000) |
Links
PUBLIC
- Website: https://www.joinmidi.com
- LinkedIn: https://www.linkedin.com/company/midi-health/life
Executive Summary
PUBLIC
Midi Health is a virtual clinic building a national healthcare company by targeting the historically underserved but high-cost market of women's midlife health, starting with perimenopause and menopause [Sacra]. The company deserves investor attention for its multi-channel distribution strategy, its focus on a demographic segment representing an estimated 50 million U.S. women, and its rapid accumulation of venture capital, including a recent Series D that reportedly valued the business at $1 billion [FierceHealthcare], [joinmidi.com]. Founded in 2021 by CEO Joanna Strober, a former venture investor and founder of the digital health company Kurbo Health, alongside clinical leaders Dr. Ariel D. N. Harlev and Dr. Kathleen Jordan, the team combines startup operational experience with deep medical expertise in reproductive endocrinology and internal medicine [1843 Capital], [Avestria Ventures]. Its core service offers insurance-covered telehealth visits with specially trained clinicians, personalized care plans, and prescriptions, delivered through direct-to-consumer, employer benefit, and health system partnership channels [PR Newswire, January 2024]. The company has raised over $100 million in disclosed capital across multiple rounds led by firms including GV, Emerson Collective, and Goodwater Capital, with a business model predicated on capturing recurring revenue through employer contracts and payer reimbursements [PR Newswire, April 2024], [Healthcare-Brew, February 2026]. Key developments to watch over the next 12-18 months include the scaling of its recently launched longevity arm, the integration of its proprietary AI tools for clinician training and patient search, and its ability to convert its early leadership in a fragmented market into a defensible, scaled network [Business Insider, October 2025], [Fortune, May 2025].
Data Accuracy: GREEN -- Core company details, funding rounds, and product claims are confirmed by company press releases, investor materials, and business publications. The $1 billion valuation is reported by a single trade publication.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Series D+ |
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $100M+ |
Company Overview
PUBLIC
Midi Health, a virtual clinic for women's midlife health, was founded in 2021 in Palo Alto, California [ZoomInfo]. The company's origin story centers on a clinical gap: co-founders Joanna Strober and Dr. Ariel D. N. Harlev identified perimenopause and menopause as historically underserved, high-cost segments of healthcare, with an estimated 50 million women in the U.S. navigating these transitions [joinmidi.com]. The founding team, which also included early Chief Medical Officer Dr. Kathleen Jordan, structured the business from the outset to accept insurance, positioning it as a specialist telehealth service rather than a cash-pay wellness offering [joinmidi.com].
Key operational milestones followed a rapid fundraising cadence. After a $14 million seed round closed in October 2022, the company launched its virtual care platform [Sacra]. By September 2023, a $25 million Series A led by GV (Google Ventures) funded a national expansion of clinical operations [Sacra]. A significant partnership was announced in October 2023 with Memorial Hermann Health System to provide care for women in Houston, marking an early health system integration [Memorial Hermann, October 2023]. In January 2024, Midi announced its services were available as an employer benefit in all 50 states, a key step in its B2B2C distribution strategy [PR Newswire, January 2024].
The company's growth trajectory accelerated with a $60 million Series B in April 2024, which brought its total disclosed funding to $100 million at that time [PR Newswire, April 2024]. Subsequent rounds, including a $100 million Series D led by Goodwater Capital reported in February 2026, have supported further scaling, the launch of a longevity-focused service arm, and investments in AI-driven clinical tools [Healthcare-Brew, February 2026] [Fortune, May 2025]. Headcount has scaled accordingly, from an estimated 275 employees in earlier data to approximately 652 by April 2026 [ZoomInfo] [LeadIQ, April 2026].
Data Accuracy: GREEN -- Confirmed by company website, press releases, and investor databases.
Product and Technology
MIXED
Midi Health's core offering is a virtual clinic delivering insurance-covered care for perimenopause, menopause, and other midlife health issues. The product is a telehealth platform that connects patients with a network of clinicians trained in midlife women's health, offering virtual visits, personalized care plans, lab testing, and prescriptions, including hormone therapy [joinmidi.com]. The company emphasizes that its care is covered by major insurers, positioning it as a typical specialist appointment rather than a cash-pay service [joinmidi.com]. This model is distributed through three channels: direct-to-consumer bookings, employer-sponsored benefits, and partnerships with health systems like Memorial Hermann [PR Newswire, January 2024] [Sacra].
Beyond the core clinical service, Midi is developing an AI layer to scale its operations and enhance care. Public reporting indicates the company is building its own AI search engine for women's health and using AI to train providers [Business Insider, October 2025]. Proceeds from its Series C funding are earmarked for developing AI-powered clinical decision support tools and a specialized women's health search engine [Sacra]. The company has also launched a longevity arm to expand its reach, signaling a product evolution beyond the initial hormonal health wedge [Fortune, May 2025].
Data Accuracy: GREEN -- Product details confirmed by company website and press releases; AI initiatives reported by multiple business publications.
Market Research
PUBLIC
The market for midlife women's health, long dismissed as a niche, has become a primary target for venture capital and corporate benefits due to its sheer demographic scale and the rising economic cost of untreated symptoms.
A foundational driver is the size of the population. Midi Health cites a target segment of approximately 50 million U.S. women navigating perimenopause and menopause, a figure frequently referenced in the company's own materials [joinmidi.com]. This demographic is not only large but is entering a life stage with higher disposable income and increasing workforce participation, creating a concentrated demand for convenient, specialized care. The broader U.S. women's digital health market, which includes fertility, pregnancy, and general wellness, was valued at over $2.5 billion in 2023 and is projected to grow at a compound annual rate above 15% through 2030, according to analogous market reports from Grand View Research [Grand View Research, 2023]. The menopause-specific sub-segment within this is one of the fastest-growing, though precise public third-party sizing remains limited.
Demand is further propelled by a confluence of social, economic, and clinical tailwinds. Public awareness campaigns and high-profile advocacy have destigmatized discussions around menopause, shifting it from a private concern to a recognized workplace and healthcare issue. From an employer perspective, the economic argument is compelling. Untreated menopausal symptoms are linked to increased absenteeism, presenteeism, and turnover, with one study by the Mayo Clinic estimating the annual productivity loss in the U.S. at roughly $1.8 billion [Mayo Clinic, 2022]. This has catalyzed a rapid expansion of employer-sponsored women's health benefits, creating a ready-made B2B2C channel for virtual clinics. On the clinical side, a documented shortage of providers trained in menopause care creates a supply gap that virtual, specialized networks are positioned to fill [The Lancet, 2022].
Key adjacent and substitute markets influence the competitive landscape and potential expansion paths. The broader longevity and healthy aging market represents a natural adjacency, which Midi has begun to explore with its dedicated longevity arm launched in 2025 [Fortune, May 2025]. Traditional substitutes include fragmented care from primary care physicians and OB/GYNs, who often lack specific training, and direct-to-consumer cash-pay telehealth services for hormone replacement therapy (HRT). The regulatory environment presents both a tailwind and a watch item. The FDA's 2023 guidance on developing treatments for vasomotor symptoms (hot flashes) signals regulatory attention on the category. However, the classification of digital therapeutics and the reimbursement landscape for virtual chronic care management remain evolving, with policy changes potentially impacting coverage models.
| Metric | Value |
|---|---|
| U.S. Women in Target Segment | 50 million |
| Analogous Digital Women's Health Market (2023) | 2.5 $B |
| Projected Market Growth Rate (to 2030) | 15 % |
The chart underscores the core investment thesis: a massive, engaged demographic is underserved by the current care infrastructure, and the economic incentives for employers to address it are becoming quantifiably clear. The growth rate of the broader category suggests the underlying demand is not a transient trend.
Data Accuracy: YELLOW -- The core demographic figure is company-sourced; the analogous market size and growth rate are from a third-party report. The productivity cost estimate is from an academic medical center.
Competitive Landscape
MIXED
Midi Health's competitive position is defined by its singular focus on midlife hormonal health as a wedge, a strategy that pits it against both broad-spectrum women's health platforms and a growing cohort of menopause-specific digital clinics. The company describes itself as the "only comprehensive virtual care clinic for women in midlife navigating perimenopause, menopause, and other common midlife health challenges" [LinkedIn].
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Midi Health | Comprehensive, insurance-covered virtual clinic for perimenopause, menopause, and midlife health. | Series D+, ~$150M (estimated) total funding [Femtech Insider] | Multi-channel distribution (employer, health system, DTC) and focus on insurance integration. | [PR Newswire, April 2024] |
| Maven Clinic | Full-spectrum family and women's health platform from fertility through parenting. | Unicorn, $300M+ total funding [Crunchbase] | Breadth of services across the reproductive lifecycle and established enterprise footprint. | [Crunchbase] |
| Elektra Health | Digital clinic and education platform focused on menopause. | Seed stage, $4.8M (estimated) total funding [Crunchbase] | Strong emphasis on community and content-led patient acquisition. | [Crunchbase] |
| Peppy | B2B2C digital health platform offering specialist support for underserved health areas, including menopause. | Series B, $45M+ total funding [Crunchbase] | European roots and a multi-condition platform model (menopause, fertility, men's health). | [Crunchbase] |
| Evernow | Direct-to-consumer telehealth platform for menopause treatment and care. | Series A, $28.5M total funding [Crunchbase] | Cash-pay, subscription-based model with a streamlined DTC user experience. | [Crunchbase] |
The competitive map segments into three tiers. The primary challengers are scaled, venture-backed platforms like Maven Clinic, which compete for the same employer benefit budgets but with a broader lifecycle focus that can dilute menopause-specific expertise. The second tier consists of focused digital clinics like Elektra Health, Evernow, and Winona, which target the same patient demographic but often through different commercial models, such as direct-to-consumer subscriptions or cash-pay prescriptions. Adjacent substitutes include traditional care channels: fragmented primary care and OB/GYN networks, which remain the default for most patients despite documented gaps in menopause training, and pharmaceutical companies marketing hormone therapies directly to consumers.
Midi Health's defensible edge today rests on two integrated pillars: its payer and employer distribution. The company's early and consistent emphasis on being "insurance-covered" and contracting with major insurers creates a significant reimbursement and access moat versus cash-pay competitors [joinmidi.com]. This is compounded by its announced 50-state availability for employers, a logistical and contractual feat that few pure-play menopause startups have matched [PR Newswire, January 2024]. This edge is durable if Midi can maintain superior unit economics and clinical outcomes that justify its place on employer benefit menus, but it is perishable if larger platforms or incumbent health plans decide to build comparable, in-house menopause programs.
The company's most significant exposure is in the direct-to-consumer channel, where it faces agile, marketing-driven competitors. While Midi accepts direct patient bookings, its public narrative and recent funding are heavily geared towards B2B2C scale [PR Newswire, April 2024] [Healthcare-Brew, February 2026]. A competitor like Evernow, with a focused DTC subscription model, could build a stronger brand affinity and patient relationship outside the constraints of employer benefit cycles. Furthermore, Midi's expansion into a "longevity arm" introduces competition with a much wider set of wellness and primary care providers, potentially diluting its specialist focus [Fortune, May 2025].
The most plausible 18-month scenario is consolidation within the menopause-focused digital health segment, driven by the capital requirements to build nationwide clinical networks and secure payer contracts. The winner will likely be the company that most effectively leverages proprietary data and AI to demonstrate lower employer healthcare costs and superior patient retention. Midi is positioned as a winner if its AI-driven clinical decision support and provider training tools yield measurable reductions in specialist referrals or ER visits for menopause symptoms [Business Insider, April 2026] [Let's Data Science]. A loser in this scenario would be a DTC-only competitor that fails to secure insurance reimbursement or employer partnerships, limiting its total addressable market and margin profile as the market matures beyond early adopters willing to pay out-of-pocket.
Data Accuracy: GREEN -- Competitor funding and positioning corroborated by Crunchbase; Midi's differentiation claims sourced from company press releases.
Opportunity
PUBLIC The prize for Midi Health is the chance to become the dominant, longitudinal care platform for the 50 million women in the United States navigating midlife health, a segment historically underserved by both primary care and traditional obstetrics [joinmidi.com].
The headline opportunity is to build the category-defining women's health platform for the 40+ demographic, starting with perimenopause and menopause as a wedge. The evidence for this outcome being reachable, rather than purely aspirational, rests on the company's multi-channel distribution strategy already in motion. Midi has secured a position as an employer-sponsored benefit available in all 50 states, a channel that provides predictable, recurring revenue and deep integration into healthcare benefits [PR Newswire, January 2024]. Simultaneously, it has established partnerships with health systems like Memorial Hermann, embedding its virtual clinic within traditional care delivery networks [Memorial Hermann, October 2023]. This dual-track approach to market capture is a more defensible path to scale than a pure direct-to-consumer model, suggesting the company is building the infrastructure to become a default, in-network option for midlife women's care.
Several concrete growth scenarios could propel the company to that scale. The most immediate is a land-and-expand motion within the employer channel, using perimenopause support as an entry point to become a comprehensive women's health and longevity benefit.
| Metric | Value |
|---|---|
| Employer Benefit Penetration | 50 states |
| Health System Partnerships | 1 confirmed partner |
| Direct Patient Access | 50 states |
The chart shows Midi's current geographic footprint, which provides the foundation for these scenarios. Each scenario represents a path to massive, defensible scale.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Employer Land-and-Expand | Midi becomes a standard Fortune 500 healthcare benefit, then expands services into broader longevity, mental health, and chronic condition management for women. | A marquee enterprise customer announcement, demonstrating high employee uptake and measurable ROI on retention and healthcare costs. | The company has already announced 50-state availability for employers and frames its service explicitly as a tool for retention and cost reduction [PR Newswire, January 2024]. |
| Health System White-Label | Midi's virtual care platform and clinician network become the outsourced women's health specialty arm for dozens of regional health systems. | A second major health system partnership announcement following the Memorial Hermann model, potentially in a different geographic region. | The Memorial Hermann partnership demonstrates a model where Midi extends the reach of a traditional system's women's services [Sacra]. Health systems face specialist shortages and seek virtual partners. |
| AI-Powered Care Navigation | The company's proprietary search engine and clinical decision support tools become the trusted source for women's health information, driving patient acquisition and deepening engagement. | The launch of a publicly available, AI-powered search tool for women's health, as indicated by plans for its Series C proceeds [Sacra]. | Midi is actively developing AI for clinician training and workflow support, building an internal knowledge base that could be productized [Business Insider, April 2026]. |
What compounding looks like is a flywheel powered by clinical data and network density. Each new employer or health system partnership delivers more patients into Midi's care model. That growing patient population generates proprietary data on treatment protocols and outcomes for midlife women's conditions, which in turn refines the company's AI tools and care pathways [Business Insider, October 2025]. These improved protocols can enhance patient outcomes, which strengthens Midi's value proposition to payers and employers, making it easier to secure more partnerships. This data moat and clinical network effect would become increasingly difficult for new entrants to replicate, as they would lack the longitudinal patient records and optimized care protocols Midi would accumulate.
The size of the win can be framed by looking at a comparable. Maven Clinic, a broader women's and family health virtual care platform, achieved a valuation reported at over $1 billion in 2021 [Forbes]. Midi's specific, deep focus on the 40+ demographic and its insurance-covered, multi-distribution model presents a path to a similar or greater scale within its more concentrated segment. If the "Employer Land-and-Expand" scenario plays out, Midi could plausibly capture a significant portion of the large employer market for women's health benefits. While specific revenue projections are not public, the company's $1 billion valuation as of its Series D indicates investor confidence in this outcome [FierceHealthcare]. A successful execution could see the company become a multi-billion dollar standalone platform or an acquisition target for a major payer or health system seeking to own the senior women's health journey (scenario, not a forecast).
Data Accuracy: YELLOW -- The core market size and distribution claims are from the company's own materials. The growth scenarios are extrapolations based on announced partnerships and product direction, which are publicly cited. Valuation and competitor scale are from single-source media reports.
Sources
PUBLIC
[Sacra] Midi Health | https://sacra.com/c/midi-health
[FierceHealthcare] Women's health clinic Midi Health closes $100M series D as it aims to scale a national healthcare company | https://www.fiercehealthcare.com/health-tech/womens-health-clinic-midi-health-closes-100m-series-d-round-hitting-1b-valuation
[joinmidi.com] Midi Health | https://www.joinmidi.com
[1843 Capital] Joanna Strober | https://1843capital.com/joins-1843-capital-as-partner/
[Avestria Ventures] Avestria Ventures - Midi Health | https://www.avestria.vc/midi-health
[PR Newswire, January 2024] Midi Health announces 50-state availability for employers | https://www.prnewswire.com/news-releases/midi-health-announces-50-state-availability-for-employers-301970261.html
[Healthcare-Brew, February 2026] Women's health startup Midi Health closes $100 million Series D | https://www.healthcare-brew.com/stories/2026/02/03/midi-health-series-d-funding
[Fortune, May 2025] Midi Health launches longevity arm | https://fortune.com/2025/05/midi-health-longevity-launch
[Business Insider, October 2025] Midi Health raises $50 million in funding as the menopause startup bets on longevity and AI | https://www.businessinsider.com/womens-health-startup-midi-health-50-million-longevity-ai-2025-10
[PR Newswire, April 2024] Midi Health, the fastest-growing virtual clinic for perimenopause and menopause, raises an additional $60M in Series B round | https://www.prnewswire.com/news-releases/midi-health-the-fastest-growing-virtual-clinic-for-perimenopause-and-menopause-raises-an-additional-60m-in-series-b-round--100m-total-funding-to-date--to-transform-womens-healthcare-302125839.html
[ZoomInfo] Midi Health - ZoomInfo | https://www.zoominfo.com/c/midi-health/566132142
[LeadIQ, April 2026] Midi Health company profile | https://www.leadiq.com/company/midi-health
[Memorial Hermann, October 2023] Memorial Hermann partners with Midi Health | https://www.memorialhermann.org/newsroom/2023/memorial-hermann-partners-with-midi-health
[Business Insider, April 2026] Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything. | https://www.businessinsider.com/how-midi-health-is-using-ai-to-transform-care-scale-2026-4
[Let's Data Science] Midi Health uses AI to train clinicians and scale care for menopausal women | https://www.letsdatascience.com/midi-health-ai-clinician-training
[LinkedIn] Midi Health | LinkedIn | https://www.linkedin.com/company/midi-health/life
[Femtech Insider] Midi Health raises $50M Series C | https://www.femtechinsider.com/midi-health-series-c-50m
[Crunchbase] Maven Clinic - Crunchbase Company Profile | https://www.crunchbase.com/organization/maven-clinic
[Crunchbase] Elektra Health - Crunchbase Company Profile | https://www.crunchbase.com/organization/elektra-health
[Crunchbase] Peppy - Crunchbase Company Profile | https://www.crunchbase.com/organization/peppy-health
[Crunchbase] Evernow - Crunchbase Company Profile | https://www.crunchbase.com/organization/evernow
[Forbes] Maven Clinic | Forbes | https://www.forbes.com/companies/maven-clinic
[Grand View Research, 2023] Women's Digital Health Market Size Report | https://www.grandviewresearch.com/industry-analysis/womens-digital-health-market
[Mayo Clinic, 2022] The economic burden of menopausal symptoms | https://www.mayoclinicproceedings.org/article/S0025-6196(22)00456-7/fulltext
[The Lancet, 2022] The global shortage of menopause-care providers | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01234-5/fulltext
Articles about Midi Health
- Midi Health's 50-State Clinic Is a Wedge Into the $1 Billion Menopause Market — The virtual care startup has raised over $100 million to build an insurance-covered model for perimenopause, betting AI can scale a historically fragmented clinical pathway.